Blood cancer drug Imbruvica among Biden's picks for Medicare price talks

Plus: How the future of obesity medicine might parallel that of cancer

August 29, 2023 Check out STAT+

Sponsored By

Anna Moneymaker/Getty Images Here are the 10 drugs that will be up first for Medicare price negotiation Medicare has announced the first 10 medicines that will be up first in its new drug price negotiation program. By Rachel Cohrs and Matthew Herper STAT+ | FDA delays enforcement of a pharmaceutical supply chain law to stop counterfeit drugs As a Nov. 27, deadline for compliance approached, concern had grown that too many companies are not fully prepared to comply with the law. By Ed Silverman STAT+ | What do new weight loss drugs mean for the future of bariatric surgery? New weight loss drugs have captured the public's imagination but also raised existential questions about the future of bariatric surgery. By Simar Bajaj

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser